XML 46 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Selected Quarterly Data (Unaudited) (Tables)
 12 Months Ended
Mar. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Data
The following table presents selected unaudited quarterly financial data of the Company for the years ended March 31, 2018 and 2017. The unaudited quarterly financial data is prepared on the same basis as the audited consolidated financial statements. The Company’s operating results for any quarter are not necessarily indicative of the operating results for any future quarters or a full year. The net loss per common share amounts for the 2018 and 2017 quarters have been computed separately.

 
First Quarter Ended
 
Second Quarter Ended
 
Third Quarter Ended
 
Fourth Quarter Ended
 
First Quarter Ended
 
Second Quarter Ended
 
Third Quarter Ended
 
Fourth Quarter Ended
 
June 30,
 
September 30,
 
December 31,
 
March 31,
 
June 30,
 
September 30,
 
December 31,
 
March 31,
 
2017
 
2017
 
2017
 
2018
 
2016 (1)
 
2016
 
2016
 
2017
Total operating expenses
$
21,890

 
$
30,311

 
$
41,515

 
$
47,347

 
$
17,135

 
$
6,720

 
$
9,056

 
$
22,946

Net loss
$
(23,317
)
 
$
(29,908
)
 
$
(41,777
)
 
$
(48,253
)
 
$
(18,970
)
 
$
(34,712
)
 
$
(8,083
)
 
$
(21,675
)
Net loss per share attributable to common shareholders - basic and diluted
$
(0.39
)
 
$
(0.50
)
 
$
(0.70
)
 
$
(0.81
)
 
$
(0.47
)
 
$
(0.82
)
 
$
(0.15
)
 
$
(0.37
)

(1)
On April 29, 2016, the Company entered into a license agreement with Takeda. As a result of this transaction, the Company recorded $13.1 million as R&D expense at the closing date of the acquisition of the rights, which consisted of $7.7 million for the estimated fair value of the 5,077,001 common shares issued and $5.4 million for the estimated fair value of Takeda warrant liability. Refer to Note 3 for additional information.